Aging DisorderBVE-HAPINCT07734246
Healthy Aging Together - "Getting to Know You Better": Healthy Aging and Predictive Indicator
A study testing Health assessment in people with Aging Disorder, run by Centre Hospitalier Universitaire de Nice.
Trial summary
A key challenge lies in preventing the loss of autonomy and promoting healthy aging-a concept now widely addressed through multidimensional and multidisciplinary approaches, as evidenced by frailty models, comprehensive geriatric assessment practices, and the WHO's "intrinsic capacity" model. Read more about this study
- Who is it for?
- Ages 55 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aging Disorder
- What is being tested?
- Health assessment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 500 participants
- Where
- No sites listed yet
- Study dates
- Nov 2026to Mar 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 55 years or older
- Affiliation with or beneficiary of a social security scheme
- No objection to the study
Who cannot join
- Persons protected by law, under guardianship or curatorship,
- Persons deprived of liberty
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Lyne DAUMAS contact
About this study
A key challenge lies in preventing the loss of autonomy and promoting healthy aging-a concept now widely addressed through multidimensional and multidisciplinary approaches, as evidenced by frailty models, comprehensive geriatric assessment practices, and the WHO's "intrinsic capacity" model. That said, there is a need to assess in greater detail the extent to which individual factors contribute to health trajectories and to move further by adopting a systemic approach that examines not only the relationships between variables but also their complex interactions. The aim of this study is to identify the multidimensional determinants (medical, physical, nutritional, sensory, psycho-cognitive, psychosocial, and socioeconomic) associated with the autonomy and quality of life of older adults and those who are aging.
- Conditions
- Aging Disorder
- Being tested
- Health assessment
- Keywords
- healthy aging, autonomy, geriatric
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health assessmentOther
Questionnaires and tests on health behaviors and health
| Study group | Role | What they receive |
|---|---|---|
| Assessed group | Experimental | Not described Receives: Other: Health assessment |
What is being measured
The primary outcome is the main question the study is designed to answer.
assessment of Autonomy
Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton.
The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better.
Measured: at baseline, 6 months later and 12 months later
Secondary outcomes (10)
Quality of life
Quality of life is assessed using the EuroQol at 5 dimensions (EQ-5D) questionnaire.
The scale comprises 5 items. Each item is scored from 1 "no problem" to 3 "severe problem". The total score ranges from 5 to 15 with higher score indicating a worse outcome.
Measured: at baseline, 6 months later and 12 months later
Daily Physical activity Practice (physical behavioral lifestyle measure
Daily Physical activity Practice is assessed using the Marshall questionnaire comprising 2 items. The total score ranges from 0 to 8. A higher score means a higher level of physical activity. The cut of 4 correspond to "sufficiently active".
Measured: at baseline, 6 months later and 12 months later
Sarcopenia (physical measure)
Sarcopenia is assessed using the SARC-F questionnaire comprising 5 items assessing force, walk difficulties, stand up capacities, climb stairs capacities and fall. Each item is scored from 0 to 2. The total score ranges from 0 to 10 with higher score indicating a worse outcome
Measured: at baseline, 6 months later and 12 months later
Physical functional force (physical measure)
Physical functional force is assessed using the 5 sit-to-stand test wich consists of asking the participant to stand up and sit down from a chair 5 times as quickly as possible. The outcome is the time taken to complete the test, and the unit of measurement is seconds.
Measured: at baseline, 6 months later and 12 months later
Eating habits (nutritional behavioral lifestyle measure
Eating habits is assessed using items from the Senior in the Community: Risk Evaluation for Eating and Nutrition (SCREEN) questionnaire. Higher score indicated better eating habits.
Measured: at baseline, 6 months later and 12 months later
Body Mass Index (nutritional measure)
Body Mass Index corresponds to corresponds to weight (kg) divided by height (m) squared. The unit is kg/m2.
Measured: at baseline, 6 months later and 12 months later
Subjective cognitive complaint (cognitive measure)
Subjective cognitive complaint is assessed using items from the ICOPE cohort, regarding the presence and worsening (yes/no) of memory and orientation problems
Measured: at baseline, 6 months later and 12 months later
Working memory (cognitive measure)
Working memory is assessed using a visual test consisting of remembering the order in which targets are illuminated. More recalls correspond to a better score.
Measured: : at baseline, 6 months later and 12 months later
Psychological quality (psychological measure)
Psychological quality is assessed using items from the World Health Organization Quality of Life-Spirituality, Religiousness and Personal Beliefs (WHOQOL-SRPB) questionnaire. Each item is scored from 1 to 5. Higher score is better.
Measured: at baseline, 6 months later and 12 months later
Locus of Control (psycho-social measure)
: Locus of Control is assessed using items from the Multidimensional Health Locus of Control Scale. It is a 5-point Likert scale. The questionnaire helps to see if the person thinks that their health depends mainly on their own behavior, that it is perceived as being linked to chance, or that it depends mainly on professionals.
Measured: at baseline, 6 months later and 12 months later
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2026
- Study startNov 2026 (estimated)
- Primary completionNov 2028 (estimated)
- Study completionMar 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Aging DisorderStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NiceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07734246
- Sponsor's protocol ID
- 25-PP-30
- Acronym
- BVE-HAPI
- Status last verified
- Jul 2026
- First submitted
- 24 Jul 2026
- Last updated
- 29 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Healthy Aging Together - "Getting to Know You Better": Healthy Aging and Predictive Indicator
- ClinicalTrials.gov ID
- NCT07734246
- Acronym / sponsor ID
- BVE-HAPI / 25-PP-30
- Conditions
- Aging Disorder
- Keywords
- healthy aging, autonomy, geriatric
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de NiceUniversity, hospital or other
- Study start
- Nov 2026 (estimated)
- Primary completion
- Nov 2028 (estimated)
- Study completion
- Mar 2029 (estimated)
- First posted
- 29 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A key challenge lies in preventing the loss of autonomy and promoting healthy aging-a concept now widely addressed through multidimensional and multidisciplinary approaches, as evidenced by frailty models, comprehensive geriatric assessment practices, and the WHO's "intrinsic capacity" model. That said, there is a need to assess in greater detail the extent to which individual factors contribute to health trajectories and to move further by adopting a systemic approach that examines not only the relationships between variables but also their complex interactions. The aim of this study is to identify the multidimensional determinants (medical, physical, nutritional, sensory, psycho-cognitive, psychosocial, and socioeconomic) associated with the autonomy and quality of life of older adults and those who are aging.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Assessed group | Experimental | Other: Health assessment |
Who may qualify
- Ages
- 55 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age 55 years or older
- Affiliation with or beneficiary of a social security scheme
- No objection to the study
Key exclusion criteria (2 listed)
- Persons protected by law, under guardianship or curatorship,
- Persons deprived of liberty
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health assessmentQuestionnaires and tests on health behaviors and health | Other | Assessed group |
Primary outcome
assessment of Autonomy
Time frame: at baseline, 6 months later and 12 months later
Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton. The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better.
10 secondary outcomes
Quality of life
Time frame: at baseline, 6 months later and 12 months later
Daily Physical activity Practice (physical behavioral lifestyle measure
Time frame: at baseline, 6 months later and 12 months later
Sarcopenia (physical measure)
Time frame: at baseline, 6 months later and 12 months later
Physical functional force (physical measure)
Time frame: at baseline, 6 months later and 12 months later
Eating habits (nutritional behavioral lifestyle measure
Time frame: at baseline, 6 months later and 12 months later
Body Mass Index (nutritional measure)
Time frame: at baseline, 6 months later and 12 months later
Subjective cognitive complaint (cognitive measure)
Time frame: at baseline, 6 months later and 12 months later
Working memory (cognitive measure)
Time frame: : at baseline, 6 months later and 12 months later
Psychological quality (psychological measure)
Time frame: at baseline, 6 months later and 12 months later
Locus of Control (psycho-social measure)
Time frame: at baseline, 6 months later and 12 months later
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2026.
Related trials for Aging Disorder
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Enrolling by invitation
Promoting Aging and Thriving With HIV
HIV (Human Immunodeficiency Virus), Geriatric
RecruitingObservational study
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Lyne DAUMAS contact
Questions about this trial
What is this clinical trial studying?
A study testing Health assessment in people with Aging Disorder, run by Centre Hospitalier Universitaire de Nice.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Olivier GUERIN, PROFESSOR (+33492034194, guerin.o@chu-nice.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
assessment of Autonomy (time frame: at baseline, 6 months later and 12 months later). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.